Formidable Asset Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-16,266
Closed -$202K 211
2016
Q4
$202K Buy
16,266
+1,100
+7% +$13.2K 0.1% 157
2016
Q3
$208K Buy
15,166
+1,686
+13% +$16.9K 0.1% 155
2016
Q2
$102K Buy
+13,480
New +$101K 0.06% 154

Other funds holding ARIA

Formidable Asset Management's ARIA Position: Q1 2017 in Review

Formidable Asset Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 16,266 shares — an estimated $202K sold.

Formidable Asset Management first reported a position in ARIA in Q2 2016 and held it in 3 quarters. The position peaked at $208K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Formidable Asset Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Formidable Asset Management sold 16,266 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $202K.
  • Formidable Asset Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2016 and held it in 3 quarters.
  • Formidable Asset Management's Ariad Pharmaceuticals Inc position peaked at $208K in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Formidable Asset Management's 13F filing for Q1 2017, filed 12 May 2017.